{"abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with Agency guidance documents pertaining to pharmacies, outsourcing facilities, and other entities with regard to human drug compounding, repackaging, and related activities.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/06/12/2024-12783.html","cfr_references":[],"citation":"89 FR 49880","comment_url":null,"comments_close_on":"2024-08-12","correction_of":null,"corrections":[],"dates":"Either electronic or written comments on the collection of information must be submitted by August 12, 2024.","disposition_notes":null,"docket_ids":["Docket No. FDA-2024-N-2583"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2024-06-12","updated_at":"2024-09-03T17:05:22.374-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2024-N-2583-0001","allow_late_comments":false,"id":"FDA-2024-N-2583-0001","comment_end_date":"2024-08-13","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2024-N-2583","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act"}],"document_number":"2024-12783","effective_on":null,"end_page":49884,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/06/12/2024-12783.xml","html_url":"https://www.federalregister.gov/documents/2024/06/12/2024-12783/agency-information-collection-activities-proposed-collection-comment-request-human-drug-compounding","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-12783?publication_date=2024-06-12","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-06-12/2024-12783/mods.xml","not_received_for_publication":null,"page_length":5,"page_views":{"count":189,"last_updated":"2026-04-04 12:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-06-12/pdf/2024-12783.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-12783.pdf?1718109922","publication_date":"2024-06-12","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/06/12/2024-12783.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2024-N-2583","supporting_documents_count":0,"docket_id":"FDA-2024-N-2583","document_id":"FDA-2024-N-2583-0001","regulation_id_number":null,"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act","checked_regulationsdotgov_at":"2024-08-13T04:04:37Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":49880,"subtype":null,"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act","toc_doc":"Human Drug Compounding, Repackaging, and Related Activities Regarding the Federal Food, Drug, and Cosmetic Act","toc_subject":"Agency Information Collection Activities; Proposals, Submissions, and Approvals:\n","topics":[],"type":"Notice","volume":89}